Shenzhen Kangtai Biological Products Co.,Ltd.

BioKangtai established in 1992, focusing on the R&D, production and distribution of human preventive vaccines, listed on the Shenzhen Stock Exchange on February 7, 2017 (stock code:300601), also is the first listed vaccine enterprise in South China. As one of the largest private vaccines manufacturers in China, BioKangtai owns 5 vaccine centers across 2 major cities: 3 centers in Shenzhen and 2 ce...